Pharmacyte Biotech Stock Technical Analysis
| PMCB Stock | USD 1.56 0.01 0.64% |
As of the 25th of March, PharmaCyte Biotech holds the Coefficient Of Variation of (10,384), risk adjusted performance of (0.001), and Variance of 15.3. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of PharmaCyte Biotech, as well as the relationship between them.
PharmaCyte Biotech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as PharmaCyte, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PharmaCytePharmaCyte |
PharmaCyte Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
PharmaCyte Biotech Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of PharmaCyte Biotech volatility. High ATR values indicate high volatility, and low values indicate low volatility.
PharmaCyte Biotech Trend Analysis
Use this graph to draw trend lines for PharmaCyte Biotech. You can use it to identify possible trend reversals for PharmaCyte Biotech as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual PharmaCyte Biotech price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.PharmaCyte Biotech Best Fit Change Line
The following chart estimates an ordinary least squares regression model for PharmaCyte Biotech applied against its price change over selected period. The best fit line has a slop of 0 , which means PharmaCyte Biotech will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.09, which is the sum of squared deviations for the predicted PharmaCyte Biotech price change compared to its average price change.About PharmaCyte Biotech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of PharmaCyte Biotech on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of PharmaCyte Biotech based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on PharmaCyte Biotech price pattern first instead of the macroeconomic environment surrounding PharmaCyte Biotech. By analyzing PharmaCyte Biotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of PharmaCyte Biotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to PharmaCyte Biotech specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2024 | 2025 (projected) | Dividend Yield | 0.001571 | 0.001396 | Price To Sales Ratio | 3.2K | 3.3K |
PharmaCyte Biotech March 25, 2025 Technical Indicators
Most technical analysis of PharmaCyte help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for PharmaCyte from various momentum indicators to cycle indicators. When you analyze PharmaCyte charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.001) | |||
| Market Risk Adjusted Performance | (0.05) | |||
| Mean Deviation | 2.69 | |||
| Coefficient Of Variation | (10,384) | |||
| Standard Deviation | 3.91 | |||
| Variance | 15.3 | |||
| Information Ratio | (0) | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | 0.1105 | |||
| Treynor Ratio | (0.06) | |||
| Maximum Drawdown | 19.24 | |||
| Value At Risk | (5.68) | |||
| Potential Upside | 8.0 | |||
| Skewness | 0.9069 | |||
| Kurtosis | 2.01 |
PharmaCyte Biotech March 25, 2025 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as PharmaCyte stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 273.73 | ||
| Daily Balance Of Power | (0.17) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 1.53 | ||
| Day Typical Price | 1.54 | ||
| Price Action Indicator | 0.03 |
Complementary Tools for PharmaCyte Stock analysis
When running PharmaCyte Biotech's price analysis, check to measure PharmaCyte Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaCyte Biotech is operating at the current time. Most of PharmaCyte Biotech's value examination focuses on studying past and present price action to predict the probability of PharmaCyte Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaCyte Biotech's price. Additionally, you may evaluate how the addition of PharmaCyte Biotech to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| CEOs Directory Screen CEOs from public companies around the world |